Cytosorbents Crp (CTSO)vsStryker Corporation (SYK)
CTSO
Cytosorbents Crp
$6.41
+0.63%
HEALTHCARE · Cap: $20.20M
SYK
Stryker Corporation
$275.56
+2.06%
HEALTHCARE · Cap: $105.70B
Smart Verdict
WallStSmart Research — data-driven comparison
Stryker Corporation generates 69324% more annual revenue ($25.84B vs $37.22M). SYK leads profitability with a 14.4% profit margin vs -48.9%. SYK earns a higher WallStSmart Score of 67/100 (B-).
CTSO
Avoid24
out of 100
Grade: F
SYK
Strong Buy67
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CTSO.
Margin of Safety
-19.9%
Fair Value
$229.73
Current Price
$275.56
$45.83 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Large-cap with strong market position
Strong operational efficiency at 27.0%
Earnings expanding 44.1% YoY
Generating 1.1B in free cash flow
Areas to Watch
0.2% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -540.1% — below average capital efficiency
Moderate valuation
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : CTSO
The strongest argument for CTSO centers on Debt/Equity.
Bull Case : SYK
The strongest argument for SYK centers on Market Cap, Operating Margin, EPS Growth. PEG of 1.15 suggests the stock is reasonably priced for its growth.
Bear Case : CTSO
The primary concerns for CTSO are Revenue Growth, EPS Growth, Market Cap.
Bear Case : SYK
The primary concerns for SYK are P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
CTSO profiles as a turnaround stock while SYK is a value play — different risk/reward profiles.
CTSO carries more volatility with a beta of 1.34 — expect wider price swings.
SYK is growing revenue faster at 9.4% — sustainability is the question.
SYK generates stronger free cash flow (1.1B), providing more financial flexibility.
Bottom Line
SYK scores higher overall (67/100 vs 24/100). Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cytosorbents Crp
HEALTHCARE · MEDICAL DEVICES · USA
Cytosorbents Corporation, a critical care focused immunotherapy company, is dedicated to the research, development and commercialization of medical devices with its blood purification technology platform incorporating proprietary adsorbent and porous polymer technology. The company is headquartered in Monmouth Junction, New Jersey.
Stryker Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?